Company Profile For Dr. Reddy's Laboratories Limited

Dr. Reddy’s Laboratories Limited (Dr. Reddy’s) is a global pharmaceutical company. The Company operates in three segments: Pharmaceutical Services and Active Ingredients (PSAI), which includes active pharmaceutical ingredients and intermediaries, which are the principal ingredients for finished pharmaceutical products; Global Generics, which consists of finished pharmaceutical products ready for consumption by the patient, and Proprietary Products, which involves the discovery of new chemical entities for subsequent commercialization and out-licensing. Dr. Reddy’s is vertically integrated and uses its pharmaceutical ingredients and intermediates in its own finished dosage products. The Company conducts basic research mainly in the areas of metabolic disorders, cardiovascular diseases and bacterial infection. On July 30, 2008, it acquired 85.69% interest in Perlecan Pharma Private Limited (Perlecan Pharma). Subsequently Perlecan Pharma became a wholly owned subsidiary of the Company.

BRIEF: For the three months ended 30 June 2009, Dr. Reddy's Laboratories Limited's revenues increased 19% to RS18.39B. Net income totaled RS2.39B, up from RS919.7M. Revenues reflects an increase in income from operations. Net loss reflects an decrease in research & development costs, decrease in other expenses, decrease in interest expenses and decrease in depreciation & amortization expenses. The company is a global pharmaceutical company.

Dr. Reddy's Laboratories Limited
7-1-27, Ameerpet
Hyderabad     500 016
P: +9140.23731946
F: +9140.23731955

10000